gp130受体配体作为肥胖症的潜在治疗靶点。
gp130 receptor ligands as potential therapeutic targets for obesity.
作者信息
Febbraio Mark A
机构信息
Cellular and Molecular Metabolism Laboratory, Division of Diabetes and Metabolism, Baker Heart Research Institute, Melbourne, Victoria, Australia.
出版信息
J Clin Invest. 2007 Apr;117(4):841-9. doi: 10.1172/JCI30453.
Abstract
Obesity and its related cluster of pathophysiologic conditions including insulin resistance, glucose intolerance, dyslipidemia, and hypertension are recognized as growing threats to world health. It is now estimated that 10% of the world's population is overweight or obese. As a result, new therapeutic options for the treatment of obesity are clearly warranted. Recent research has focused on the role that gp130 receptor ligands may play as potential therapeutic targets in obesity. One cytokine in particular, ciliary neurotrophic factor (CNTF), acts both centrally and peripherally and mimics the biologic actions of the appetite control hormone leptin, but unlike leptin, CNTF appears to be effective in obesity and as such may have therapeutic potential. In addition, CNTF suppresses inflammatory signaling cascades associated with lipid accumulation in liver and skeletal muscle. This review examines the potential role of gp130 receptor ligands as part of a therapeutic strategy to treat obesity.
摘要
肥胖及其相关的一系列病理生理状况，包括胰岛素抵抗、葡萄糖不耐受、血脂异常和高血压，被认为是对全球健康日益增长的威胁。据估计，目前全球10%的人口超重或肥胖。因此，显然需要新的肥胖治疗选择。最近的研究集中在gp130受体配体作为肥胖潜在治疗靶点可能发挥的作用。特别是一种细胞因子，睫状神经营养因子（CNTF），它在中枢和外周均有作用，可模拟食欲控制激素瘦素的生物学作用，但与瘦素不同的是，CNTF在肥胖治疗中似乎有效，因此可能具有治疗潜力。此外，CNTF可抑制与肝脏和骨骼肌脂质积累相关的炎症信号级联反应。本综述探讨了gp130受体配体作为肥胖治疗策略一部分的潜在作用。
相似文献
1
gp130 receptor ligands as potential therapeutic targets for obesity.gp130受体配体作为肥胖症的潜在治疗靶点。
J Clin Invest. 2007 Apr;117(4):841-9. doi: 10.1172/JCI30453.
2
Overcoming insulin resistance with ciliary neurotrophic factor.利用睫状神经营养因子克服胰岛素抵抗。
Handb Exp Pharmacol. 2011(203):179-99. doi: 10.1007/978-3-642-17214-4_9.
3
The role of gp130 receptor cytokines in the regulation of metabolic homeostasis.gp130受体细胞因子在代谢稳态调节中的作用。
J Exp Biol. 2016 Jan;219(Pt 2):259-65. doi: 10.1242/jeb.129213.
4
CNTF: a target therapeutic for obesity-related metabolic disease?睫状神经营养因子：肥胖相关代谢疾病的一种靶向治疗药物？
J Mol Med (Berl). 2008 Apr;86(4):353-61. doi: 10.1007/s00109-007-0286-y. Epub 2008 Jan 22.
5
The amino acid exchange R28E in ciliary neurotrophic factor (CNTF) abrogates interleukin-6 receptor-dependent but retains CNTF receptor-dependent signaling via glycoprotein 130 (gp130)/leukemia inhibitory factor receptor (LIFR).睫状神经营养因子（CNTF）中的氨基酸替换 R28E 可消除白细胞介素-6 受体依赖性，但通过糖蛋白 130（gp130）/白血病抑制因子受体（LIFR）保留 CNTF 受体依赖性信号转导。
J Biol Chem. 2014 Jun 27;289(26):18442-50. doi: 10.1074/jbc.M114.568857. Epub 2014 May 6.
6
[Obesity, inflammation and insulin resistance: role of gp 130 receptor ligands].[肥胖、炎症与胰岛素抵抗：gp130受体配体的作用]
An Sist Sanit Navar. 2008 May-Aug;31(2):113-23. doi: 10.4321/s1137-66272008000300002.
7
CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK.睫状神经营养因子通过激活骨骼肌中的腺苷酸活化蛋白激酶来逆转肥胖诱导的胰岛素抵抗。
Nat Med. 2006 May;12(5):541-8. doi: 10.1038/nm1383. Epub 2006 Apr 9.
8
Ciliary neurotrophic factor (CNTF): New facets of an old molecule for treating neurodegenerative and metabolic syndrome pathologies.睫状神经营养因子（CNTF）：一种古老分子在治疗神经退行性和代谢综合征疾病方面的新作用。
Cytokine Growth Factor Rev. 2015 Oct;26(5):507-15. doi: 10.1016/j.cytogfr.2015.07.007. Epub 2015 Jul 3.
9
Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance.睫状神经营养因子可纠正与瘦素缺乏及抵抗相关的肥胖和糖尿病。
Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6456-61. doi: 10.1073/pnas.94.12.6456.
10
The gp130 receptor cytokine family: regulators of adipocyte development and function.gp130 受体细胞因子家族：调节脂肪细胞的发育和功能。
Curr Pharm Des. 2011;17(4):340-6. doi: 10.2174/138161211795164202.
引用本文的文献
1
Evidence for a neuromuscular circuit involving hypothalamic interleukin-6 in the control of skeletal muscle metabolism.有证据表明，下丘脑白细胞介素-6 参与了控制骨骼肌代谢的神经肌肉回路。
Sci Adv. 2022 Jul 29;8(30):eabm7355. doi: 10.1126/sciadv.abm7355.
2
CD146 Associates with Gp130 to Control a Macrophage Pro-inflammatory Program That Regulates the Metabolic Response to Obesity.CD146 与 Gp130 结合，控制巨噬细胞促炎程序，调节肥胖的代谢反应。
Adv Sci (Weinh). 2022 May;9(13):e2103719. doi: 10.1002/advs.202103719. Epub 2022 Mar 8.
3
Mouse Microglial Calcitonin Receptor Knockout Impairs Hypothalamic Amylin Neuronal pSTAT3 Signaling but Lacks Major Metabolic Consequences.小鼠小胶质细胞降钙素受体基因敲除损害下丘脑胰淀素神经元的pSTAT3信号传导，但无主要代谢后果。
Metabolites. 2022 Jan 8;12(1):51. doi: 10.3390/metabo12010051.
4
Obesity induces morphological and functional changes in female reproductive system through increases in NF-κB and MAPK signaling in mice.肥胖通过增加 NF-κB 和 MAPK 信号通路诱导雌性生殖系统的形态和功能改变。
Reprod Biol Endocrinol. 2021 Sep 24;19(1):148. doi: 10.1186/s12958-021-00833-x.
5
COVID-19 Severity in Obesity: Leptin and Inflammatory Cytokine Interplay in the Link Between High Morbidity and Mortality.肥胖与 COVID-19 严重程度：瘦素和炎症细胞因子在高发病率和死亡率之间关联中的相互作用。
Front Immunol. 2021 Jun 18;12:649359. doi: 10.3389/fimmu.2021.649359. eCollection 2021.
6
Modulation of the Gut Microbiota Structure with Probiotics and Isoflavone Alleviates Metabolic Disorder in Ovariectomized Mice.益生菌和异黄酮调节肠道微生物群结构可缓解去卵巢小鼠的代谢紊乱。
Nutrients. 2021 May 25;13(6):1793. doi: 10.3390/nu13061793.
7
Adipocyte Oncostatin Receptor Regulates Adipose Tissue Homeostasis and Inflammation.脂肪细胞抑瘤素 M 受体调节脂肪组织稳态和炎症。
Front Immunol. 2021 Mar 29;11:612013. doi: 10.3389/fimmu.2020.612013. eCollection 2020.
8
Photoperiod Affects Leptin Action on the Choroid Plexus in Ewes Challenged with Lipopolysaccharide-Study on the mRNA Level.光照周期对脂多糖刺激的母羊脉络丛瘦素作用的影响：mRNA 水平的研究。
Int J Mol Sci. 2020 Oct 15;21(20):7647. doi: 10.3390/ijms21207647.
9
Treatment of type 2 diabetes with the designer cytokine IC7Fc.用设计细胞因子 IC7Fc 治疗 2 型糖尿病。
Nature. 2019 Oct;574(7776):63-68. doi: 10.1038/s41586-019-1601-9. Epub 2019 Sep 25.
10
High-saturated-fat diet-induced obesity causes hepatic interleukin-6 resistance via endoplasmic reticulum stress.高饱和脂肪饮食诱导的肥胖通过内质网应激引起肝脏白细胞介素 6 抵抗。
J Lipid Res. 2019 Jul;60(7):1236-1249. doi: 10.1194/jlr.M092510. Epub 2019 May 13.
本文引用的文献
1
AMP-activated protein kinase-regulated activation of the PGC-1alpha promoter in skeletal muscle cells.骨骼肌细胞中AMP激活的蛋白激酶调节的PGC-1α启动子激活
PLoS One. 2008;3(10):e3614. doi: 10.1371/journal.pone.0003614. Epub 2008 Oct 31.
2
Drug treatments for obesity: orlistat, sibutramine, and rimonabant.肥胖症的药物治疗：奥利司他、西布曲明和利莫那班。
Lancet. 2007 Jan 6;369(9555):71-7. doi: 10.1016/S0140-6736(07)60033-6.
3
Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase.白细胞介素-6通过AMP激活的蛋白激酶增加人体中胰岛素刺激的葡萄糖代谢以及体外葡萄糖摄取和脂肪酸氧化。
Diabetes. 2006 Oct;55(10):2688-97. doi: 10.2337/db05-1404.
4
Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle.白细胞介素-6对骨骼肌葡萄糖和脂质代谢作用的信号特异性
Mol Endocrinol. 2006 Dec;20(12):3364-75. doi: 10.1210/me.2005-0490. Epub 2006 Aug 31.
5
Exercise improves insulin and leptin sensitivity in hypothalamus of Wistar rats.运动可改善Wistar大鼠下丘脑的胰岛素和瘦素敏感性。
Diabetes. 2006 Sep;55(9):2554-61. doi: 10.2337/db05-1622.
6
Tumor necrosis factor inhibitors for rheumatoid arthritis.用于类风湿关节炎的肿瘤坏死因子抑制剂
N Engl J Med. 2006 Aug 17;355(7):704-12. doi: 10.1056/NEJMct055183.
7
gp130 signaling in proopiomelanocortin neurons mediates the acute anorectic response to centrally applied ciliary neurotrophic factor.促阿片黑素皮质素原神经元中的gp130信号传导介导了对中枢给予睫状神经营养因子的急性厌食反应。
Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10707-12. doi: 10.1073/pnas.0600425103. Epub 2006 Jul 3.
8
Hypothalamic mTOR signaling regulates food intake.下丘脑的mTOR信号传导调节食物摄入。
Science. 2006 May 12;312(5775):927-30. doi: 10.1126/science.1124147.
9
Overcoming insulin resistance with CNTF.利用睫状神经营养因子克服胰岛素抵抗。
Nat Med. 2006 May;12(5):511-2. doi: 10.1038/nm0506-511.
10
Ciliary neurotrophic factor suppresses hypothalamic AMP-kinase signaling in leptin-resistant obese mice.睫状神经营养因子抑制瘦素抵抗性肥胖小鼠下丘脑的AMP激酶信号传导。
Endocrinology. 2006 Aug;147(8):3906-14. doi: 10.1210/en.2005-1587. Epub 2006 May 4.
Zotero 插件